Dimensional Fund Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-171,091
Closed -$897K 3423
2024
Q1
$897K Sell
171,091
-75,406
-31% -$395K ﹤0.01% 2941
2023
Q4
$1.29M Sell
246,497
-34,191
-12% -$179K ﹤0.01% 2884
2023
Q3
$4.43M Sell
280,688
-119,811
-30% -$1.89M ﹤0.01% 2568
2023
Q2
$7.79M Sell
400,499
-57,813
-13% -$1.12M ﹤0.01% 2365
2023
Q1
$13M Buy
458,312
+108,706
+31% +$3.08M ﹤0.01% 2112
2022
Q4
$10.2K Sell
349,606
-6,153
-2% -$180 ﹤0.01% 2198
2022
Q3
$9.4M Buy
355,759
+38,083
+12% +$1.01M ﹤0.01% 2179
2022
Q2
$14.1M Buy
317,676
+12,892
+4% +$573K 0.01% 2046
2022
Q1
$15.1M Buy
304,784
+15,055
+5% +$745K ﹤0.01% 2118
2021
Q4
$14.8M Buy
289,729
+9,109
+3% +$464K ﹤0.01% 2152
2021
Q3
$15.7M Sell
280,620
-20,557
-7% -$1.15M 0.01% 2115
2021
Q2
$12.9M Sell
301,177
-26,730
-8% -$1.14M ﹤0.01% 2245
2021
Q1
$13.7M Buy
327,907
+20,897
+7% +$872K ﹤0.01% 2199
2020
Q4
$14.3M Buy
307,010
+8,718
+3% +$406K 0.01% 2127
2020
Q3
$12.7M Buy
298,292
+3,552
+1% +$151K 0.01% 2080
2020
Q2
$14.1M Sell
294,740
-1,379
-0.5% -$66.2K 0.01% 2050
2020
Q1
$13.6M Buy
296,119
+6,875
+2% +$316K 0.01% 1960
2019
Q4
$17.4M Buy
289,244
+16,034
+6% +$963K 0.01% 2110
2019
Q3
$15.5M Buy
273,210
+25,162
+10% +$1.42M 0.01% 2150
2019
Q2
$13.8M Buy
248,048
+116,443
+88% +$6.48M 0.01% 2248
2019
Q1
$6.65M Hold
131,605
﹤0.01% 2557
2018
Q4
$5.3M Buy
131,605
+48,359
+58% +$1.95M ﹤0.01% 2587
2018
Q3
$5.77M Buy
83,246
+30,410
+58% +$2.11M ﹤0.01% 2636
2018
Q2
$4M Buy
52,836
+22,960
+77% +$1.74M ﹤0.01% 2721
2018
Q1
$1.57M Sell
29,876
-496
-2% -$26.1K ﹤0.01% 2906
2017
Q4
$1.62M Sell
30,372
-2,314
-7% -$124K ﹤0.01% 2893
2017
Q3
$1.95M Buy
32,686
+388
+1% +$23.1K ﹤0.01% 2866
2017
Q2
$2.55M Buy
32,298
+24,861
+334% +$1.96M ﹤0.01% 2796
2017
Q1
$617K Hold
7,437
﹤0.01% 3064
2016
Q4
$590K Buy
+7,437
New +$590K ﹤0.01% 3065